Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,500 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD155 in tumor progression and targeted therapy.
Zhan M, Zhang Z, Zhao X, Zhang Y, Liu T, Lu L, Li XY. Zhan M, et al. Among authors: li xy. Cancer Lett. 2022 Oct 1;545:215830. doi: 10.1016/j.canlet.2022.215830. Epub 2022 Jul 20. Cancer Lett. 2022. PMID: 35870689 Review.
NKG7 Is Required for Optimal Antitumor T-cell Immunity.
Li XY, Corvino D, Nowlan B, Aguilera AR, Ng SS, Braun M, Cillo AR, Bald T, Smyth MJ, Engwerda CR. Li XY, et al. Cancer Immunol Res. 2022 Feb;10(2):154-161. doi: 10.1158/2326-6066.CIR-20-0649. Epub 2022 Jan 10. Cancer Immunol Res. 2022. PMID: 35013002
Control of Metastases via Myeloid CD39 and NK Cell Effector Function.
Yan J, Li XY, Roman Aguilera A, Xiao C, Jacoberger-Foissac C, Nowlan B, Robson SC, Beers C, Moesta AK, Geetha N, Teng MWL, Smyth MJ. Yan J, et al. Among authors: li xy. Cancer Immunol Res. 2020 Mar;8(3):356-367. doi: 10.1158/2326-6066.CIR-19-0749. Epub 2020 Jan 28. Cancer Immunol Res. 2020. PMID: 31992567
Targeting CD39 in cancer.
Moesta AK, Li XY, Smyth MJ. Moesta AK, et al. Among authors: li xy. Nat Rev Immunol. 2020 Dec;20(12):739-755. doi: 10.1038/s41577-020-0376-4. Epub 2020 Jul 29. Nat Rev Immunol. 2020. PMID: 32728220 Review.
NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophages.
Yuan D, Hu J, Ju X, Putz EM, Zheng S, Koda S, Sun G, Deng X, Xu Z, Nie W, Zhao Y, Li X, Dougall WC, Shao S, Chen Y, Tang R, Zheng K, Yan J. Yuan D, et al. Proc Natl Acad Sci U S A. 2023 Nov 21;120(47):e2302126120. doi: 10.1073/pnas.2302126120. Epub 2023 Nov 15. Proc Natl Acad Sci U S A. 2023. PMID: 37967215 Free PMC article.
ACKR4 restrains antitumor immunity by regulating CCL21.
Whyte CE, Osman M, Kara EE, Abbott C, Foeng J, McKenzie DR, Fenix KA, Harata-Lee Y, Foyle KL, Boyle ST, Kochetkova M, Aguilera AR, Hou J, Li XY, Armstrong MA, Pederson SM, Comerford I, Smyth MJ, McColl SR. Whyte CE, et al. Among authors: li xy. J Exp Med. 2020 Jun 1;217(6):e20190634. doi: 10.1084/jem.20190634. J Exp Med. 2020. PMID: 32289156 Free PMC article.
4,500 results